Andrew Lin

Andrew LIN

Advisor

Andrew currently serves as the Chairman of the Board at Lotus Pharmaceutical Co., Ltd, as an Independent Director of Fubon Life Insurance and as an Independent Director at Crown Bioscience.

Andrew has initiated and conducted several large-scale IPO, M&A and fund-raising cases when he was with the financial giants. Andrew was the General Manager of JP Morgan Securities, Chief Investment Officer of ABN AMRO Asset Management, and Managing Director of Macquarie Capital Greater China.

He has been known for sound financial structure optimization and market cap expansion when he was with corporates. On the business strategy side, Andrew served as the Chief Finance Officer of Lite-On Technology and Chief Strategy Officer of Chicony Electronics.

Andrew received his MBA degree from The University of Chicago, Graduate School of Business and an M.S. degree in electrical and computer engineering from the University of Massachusetts at Amherst.

Edward Willems

Edward WILLEMS

Managing Director & Co-founder

Ginger Hsiao

Ginger HSIAO

Co-founder

Shang Hsiao

Shang HSIAO

Co-founder and Venture Partner

Fumiaki YUMOTO, PhD

Country Head Japan, Managing Director

Jaap Weiling

Jaap WIELING

Venture Partner and Scientific Advisor

William ONG, PhD

Technical Analyst

Ha Linh NGUYEN

Technical Analyst

Jack CHAN

Financial Analyst

Emilien DUGRAND

Scientific Analyst

Sun YI

Financial Analyst

Dr. Bert Tjeenk Willink

Advisor and Venture Partner

Clark Su

Clark SU

Advisor

Adam Kirby

Adam KIRBY

Advisor

Jerry Hong

Jerry HONG

Advisor